Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries

被引:0
|
作者
Evanthia Diamanti-Kandarakis
Christina Piperi
Efstratios Patsouris
Penelope Korkolopoulou
Dimitrios Panidis
Leszek Pawelczyk
Athanasios G. Papavassiliou
Antoni J. Duleba
机构
[1] University of Athens Medical School,First Department of Internal Medicine, Endocrine section
[2] University of Athens Medical School,Department of Biological Chemistry
[3] University of Athens Medical School,Department of Pathology
[4] Aristotle University of Thessaloniki,Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynaecology, Medical School
[5] Karol Marcinkowski University of Medical Sciences,Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obstetrics
[6] Yale University School of Medicine,Department of Obstetrics and Gynecology
来源
Histochemistry and Cell Biology | 2007年 / 127卷
关键词
Advanced glycation end-products; NF-κB; Ovaries; PCOS; RAGE;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the present study was to investigate the localization/immunohistochemical distribution of AGEs and RAGE, as well as their putative signalling mediator NF-κB in ovaries of women with polycystic ovary syndrome (PCOS) compared to normal. Archival ovarian-tissue samples from biopsies of six women with PCOS and from six healthy of similar age women, were examined immunohistochemically with monoclonal anti-AGEs, anti-RAGE and anti-NF-κB(p50/p65) specific antibodies. In healthy women, AGE immunoreactivity was observed in follicular cell layers (granulosa and theca) and luteinized cells, but not in endothelial cells. PCOS specimens displayed AGE immunoexpression in theca interna and granulosa cells as well as in endothelial cells, but staining of granulosa cells was stronger than in that of normal ovaries. RAGE was highly expressed in normal and PCOS tissues. Normal tissue exhibited no staining differences between granulosa cell layer and theca interna. However, in PCOS ovaries, granulosa cells displayed stronger RAGE expression compared to theca interna cells in comparison to controls. NF-κB(p50/p65) was expressed in the cytoplasm of theca interna and granulosa cells of both normal and PCOS ovaries; whereas the NF-κB p65 subunit was only observed in granulosa cells nuclei in PCOS tissue. In conclusion, these findings demonstrate for the first time that RAGE and AGE-modified proteins with activated NF-κB are expressed in human ovarian tissue. Furthermore, a differential qualitative distribution of AGE, RAGE and NF-κB p65 subunit was observed in women with PCOS compared to healthy controls, where a stronger localization of both AGE and RAGE was observed in the granulosa cell layer of PCOS ovaries.
引用
收藏
页码:581 / 589
页数:8
相关论文
共 50 条
  • [21] Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases
    Grillo, M. A.
    Colombatto, S.
    AMINO ACIDS, 2008, 35 (01) : 29 - 36
  • [22] Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE)
    Murakami, Yoto
    Fujino, Takayuki
    Kurachi, Ryotaro
    Hasegawa, Toshiki
    Usui, Teruyuki
    Hayase, Fumitaka
    Watanabe, Hirohito
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2018, 82 (09) : 1508 - 1514
  • [23] Receptor for advanced glycation end products (RAGE) in atrial fibrillation
    Mahajan, Nitin
    Dhawan, Veena
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (05) : 5072 - 5073
  • [24] The immunobiology of the receptor of advanced glycation end-products: Trends and challenges
    Gonzalez, Ileana
    Romero, Jacqueline
    Rodriguez, Boris L.
    Perez-Castro, Ramon
    Rojas, Armando
    IMMUNOBIOLOGY, 2013, 218 (05) : 790 - 797
  • [25] Role of receptor for advanced glycation end-products in pathogenesis of psoriasis
    Soboleva, A. G.
    Bruskin, S. A.
    Nikolaev, A. A.
    Sobolev, V. V.
    Mezentsev, A. V.
    MOLECULAR BIOLOGY, 2013, 47 (05) : 645 - 654
  • [26] Reduced soluble receptor for advanced glycation end-products in COPD
    Smith, D. J.
    Yerkovich, S. T.
    Towers, M. A.
    Carroll, M. L.
    Thomas, R.
    Upham, J. W.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (03) : 516 - 522
  • [27] Role of receptor for advanced glycation end-products in pathogenesis of psoriasis
    A. G. Soboleva
    S. A. Bruskin
    A. A. Nikolaev
    V. V. Sobolev
    A. V. Mezentsev
    Molecular Biology, 2013, 47 : 645 - 654
  • [28] Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients
    Li, Jinze
    Roshelli Baker, Jacqueline
    Aglago, Elom K.
    Zhao, Zhiwei
    Jiao, Li
    Freisling, Heinz
    Hughes, David J.
    Eriksen, Anne Kirstine
    Tjonneland, Anne
    Severi, Gianluca
    Katzke, Verena
    Kaaks, Rudolf
    Schulze, Matthias B.
    Masala, Giovanna
    Pala, Valeria
    Pasanisi, Fabrizio
    Tumino, Rosario
    Padroni, Lisa
    Vermeulen, Roel C. H.
    Gram, Inger T.
    Braaten, Tonje
    Jakszyn, Paula Gabriela
    Sanchez, Maria-Jose
    Gomez-Gomez, Jesus-Humberto
    Moreno-Iribas, Conchi
    Amiano, Pilar
    Papier, Keren
    Weiderpass, Elisabete
    Huybrechts, Inge
    Heath, Alicia K.
    Schalkwijk, Casper
    Jenab, Mazda
    Fedirko, Veronika
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (11) : 1982 - 1995
  • [29] Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
    Peng, Yu
    Liu, Fubin
    Qiao, Yating
    Wang, Peng
    Du, Han
    Si, Changyu
    Wang, Xixuan
    Chen, Kexin
    Song, Fangfang
    CANCERS, 2022, 14 (24)
  • [30] Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs)
    Teodorowicz, Malgorzata
    Hendriks, Wouter H.
    Wichers, Harry J.
    Savelkoul, Huub F. J.
    FRONTIERS IN IMMUNOLOGY, 2018, 9